You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 May 2026 - Biosensing technology company DexCom Inc (Nasdaq: DXCM) announced on Monday that it has introduced Dexcom Flex, a new continuous glucose monitoring system designed for adults with Type 2 diabetes who are not on intensive insulin therapy...
18 May 2026 - Biotechnology company ImmunityBio Inc (NASDAQ: IBRX) announced on Monday the issuance of five US patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guérin (BCG) for the treatment of non-...
18 May 2026 - Endospan, a pioneer in endovascular solutions for complex aortic pathologies, announced on Monday that it has been acquired by medical device company Artivion Inc (NYSE: AORT) following US Food and Drug Administration premarket approval...
18 May 2026 - Biopharmaceutical company AstraZeneca plc (LSE: AZN) (STO: AZN) (NYSE: AZN) reported on Monday that it has received US Food and Drug Administration approval for Baxfendy (baxdrostat), the first and only aldosterone synthase inhibitor fo...
18 May 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) announced on Monday that it has entered a collaboration with AdventHealth, a US-based faith-based health system, to use its Parsortix platform in two clinical studies focused on mini...
18 May 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) disclosed on Monday that Japan's Ministry of Health, Labour and Welfare has expanded approval for its RSV vaccine, Arexvy, to include adults aged 18 to 49 years who are at in...
18 May 2026 - Atisama Therapeutics (formerly Rage Bio), an Australian clinical-stage biotechnology company, on Friday reported progress in the Phase 1 study of its lead candidate, RB042.The RB042 Phase 1 study (RB042_1001), evaluating RB042 in health...